Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bradley C Ekstrand

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Blood Reviews|July 20, 2002
Hodgkin's diseaseBradley C Ekstrand, Sandra J Horning
Current Oncology Reports|August 7, 2002
Lymphocyte predominant Hodgkin's diseaseBradley C Ekstrand, Sandra J Horning
Cancer Journal (Sudbury, Mass.)|November 6, 2002
Lymphocyte predominant Hodgkin's disease: more patience than patientsBradley C Ekstrand, Sandra J Horning
Blood|February 15, 2003
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trialBradley C Ekstrand, Jennifer B Lucas, Steven M Horwitz, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Blood Reviews|July 20, 2002
Hodgkin's diseaseBradley C Ekstrand, Sandra J Horning
Current Oncology Reports|August 7, 2002
Lymphocyte predominant Hodgkin's diseaseBradley C Ekstrand, Sandra J Horning
Cancer Journal (Sudbury, Mass.)|November 6, 2002
Lymphocyte predominant Hodgkin's disease: more patience than patientsBradley C Ekstrand, Sandra J Horning
Blood|February 15, 2003
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trialBradley C Ekstrand, Jennifer B Lucas, Steven M Horwitz, et al.
Pageof 1